ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat Discomfort

▴ ICPA Health Products
The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Mumbai, Feb 2024: India’s leading Pharma Company in the oral healthcare segment - ICPA Health Products Ltd (ICPA) has introduced its newest oral healthcare solution – Coolora Spray. Specifically designed as a mouth spray, the product effectively addresses inflammatory and painful conditions in the mouth and throat, including post-tonsillectomy pain control, pharyngitis, laryngitis, oral mucositis, mouth ulcers and burning sensations. Coolora Spray proves highly effective in reaching the tonsils and posterior pharyngeal wall, providing effective relief within just two minutes of application. Packed in a convenient 25 ml High-Density Polyethylene (HDPE) bottle equipped with a metered dose valve pump, a single spray delivers 250 micrograms of Benzydamine Hydrochloride.

ICPA has expanded its product range with the introduction of Coolora spray, alongside the existing Coolora gargle. A spray form of delivery brings unique benefits, especially in easing post-tonsillectomy surgical pain for patients who struggle with gargling after the surgery. Additionally, for children who have difficulty gargling, the spray would be more suitable because it eliminates the chances of gargle swallowing. This move reflects ICPA’s commitment to making healthcare more accessible for everyone.

The active ingredient in Coolora Spray, Benzydamine Hydrochloride 0.15 per cent, belongs to the category of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Operating in the throat and mouth, the spray effectively alleviates pain and inflammation by inhibiting the synthesis of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β).

Coolora Spray is suitable for both adults and children, with varying recommended dosages. For adults, it is advised to spray 4 to 8 puffs onto the affected area every 1½ to 3 hours. Children aged 6 to 12 years should administer four puffs, while those under 6 years old should apply one puff for every 4 kilograms of body weight, up to a maximum of four puffs, every 1½ to 3 hours.

The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief for oral and throat discomfort.

Company name: ICPA Health Products Ltd.

Product name: Coolora Spray

Qty.: 25 ml

MRP: Rs.190/-

About ICPA Health Products (ICPA): -

ICPA Health Products Ltd. is the leading Indian manufacturer in the oral healthcare segment with well-known, trusted products like Thermoseal and Hexidine. Headquartered in Mumbai, the 50 year old company has an international presence in South-East Asia, Middle-East, UK, Australia and French West Africa. In addition to dental products, ICPA also specializes in herbal and cosmetic products all of which are manufactured at its state-of-the-art, facility certified by the EU, WHO GMP and ISO in Gujarat. ICPA enjoys the franchise of around 70 per cent of India’s dental surgeons along with a significant number of ENTs and cancer specialists in the subcontinent.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024